Bicara Therapeutics Inc. Common Stock (BCAX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Bicara Therapeutics Inc. Common Stock, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Valuation | ||||
| P/E Ratio | -6.67x | -13.94x | -23.31x | -32.02x |
| P/B Ratio | 2.29x | 1.93x | 5.55x | -70.13x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||
| Current Ratio | 14.58x | 27.93x | 15.32x | 0.21x |
| Quick Ratio | 14.58x | 27.93x | 15.32x | 0.21x |
| Leverage | ||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..